The global Stem Cells Market is expected to grow at the highest CAGR of 8.61% from 2020 – 2027 and the market is projected to generate $ 17.79 billion by 2027.
Precedence Research, Recently Published Report on “Stem Cells Market (By Product Type: Adult Stem Cells, Human Embryonic Stem Cells, Very Small Embryonic Like Stem Cells, Induced Pluripotent Stem Cells; By Application: Regenerative Medicine, Drug Discovery and Development; By Technology: Cell Acquisition, Expansion and sub-culture, Cell Production, Cryopreservation; By Therapy: Autologous Stem Cell Therapy, Allogenic Stem Cell Therapy) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2020 - 2027”. The report offers an up-to-date analysis regarding the current market scenario, latest trends, key drivers, potential challenges, profitability graph and the overall market environment.
Stem cells are also called as tissue specific and can renew themselves via mitotic cell division and differentiating into an assorted range of specialized cell type. Stem cells are found in all human being, from the early stages of human development to the end of life. Human body contains stem cells and may use it whenever required. These are used to develop the adult stem cells present in the body from the development of an embryo. Cord blood processing and storage together with automation in adult stem cell are the pointer technologies anticipated to positively impact the growth of the adult cord blood stem cells market. The existence of stem cell-based treatments has been established as a clinical standard of care for different conditions such as epithelial stem cell-based therapy for burns as well as corneal disorders and hematopoietic stem cell transplant for leukemia. The potential stem cell-based therapies have expanded owing to advances in stem cell-based research.
Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1118
Growth factors
Since past few years, stem cells market is growing with the increasing investment in stem cell-based research by biopharmaceutical and pharmaceutical firm along with the success of regenerative medicines. Stem cells market is growth is backed by escalating number of clinical trials across the world. Some of the major factors driving the growth of the stem cells market include advancement in stem cell manufacturing technology as well as increasing harvest awareness regarding therapeutic potency. High occurrences of infections have steered the development of vaccines using various human diploid and non-tumorigenic cell lines.
Growing demands as well as awareness along with ongoing research and development of vaccines against different diseases are certain growth influencers of the stem cells market. Additionally, prevalence of chronic diseases will also fuel the market growth. Presence of advanced stem cells banking and availability of stem cells donor will significantly boost the market demand during upcoming years. Rigorous support of government via different initiatives aids stem cells banking to obtain significance. Increasing number of stem cells banks in emerging economies is further encouraging market penetration. Also, growing awareness about stem cell harvest which holds high potential in therapeutic and diagnosis field offers lucrative prospects to the market during impending years.
Intensifying prevalence of cancer worldwide is offering substantial boost to the growth of cancer stem cells market. As per the data published by World Health Organization, the global cancer implication is projected to have risen to around 18 million latest cases and around 9.2 million deaths in year 2018. Additionally, according to Cancer Research UK, the population enduring the cancer is anticipated to grow in near future.
Report Highlights
- Increasing prevalence of chronic diseases significantly drive the stem cells market across the globe.
- Rising Stem cell-based research and development, government initiatives and investment by pharmaceutical firms in stem cells fuel the growth of the stem cells market.
- Growing donors of stem cells and advanced stem cell banking will further propel the market growth.
- Huge success of regenerative medicines and increasing adoption of stem cell therapies are the factors projected to positively impact the stem cells market over the forecast period.
- Budding regulatory frameworks for stem cell therapeutics in Europe and the U.S.is flourishing the stem cell technology acceptance
- The cell acquisition technology dominated the stem cells market in 2019
- The Allogeneic therapy acquired largest market share among different therapy segments in 2019
Regional Snapshot
North America held the largest share in the market and is anticipated to continue its dominance over the forecast period due to existence of organized and developed healthcare systems which uplift research and development in the U.S. and Canada. Asia Pacific is likely to grow with the highest Compound Annual Growth Rate (CAGR) owing to wide usage of stem cells in regenerative medicines particularly in the sector of dermatology. Oncology applications are expected to grow at highest CAGR owing to large number of pipeline products available for the cure of cancer and tumors. Growing number of regenerative medicines centers are in turn expected to drive the stem cell in near future.
Related Reports
- Genomics Market - The global market size was valued at USD 20.06 billion in 2020 and is expected to hit over USD 72.13 billion by 2030, expanding at a compound annual growth rate (CAGR) of 13.65% during forecast period 2021 to 2030.
- Generic Drugs Market - The global market size was valued at USD 387.92 billion in 2020 and is predicted to hit around USD 675.29 billion by the end of 2030, representing impressive CAGR of 5.7% during the forecast period 2021 to 2030.
- Cancer Diagnostics Market - The global market size was valued at USD 115.60 billion in 2020 and expected to reach around USD 261.34 billion by the end of 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 8.4% during forecast period 2021 to 2030.
Key Players & Strategies
Stem Cells market is highly competitive and includes several major players such as STEMCELL Technologies, Inc., Osiris therapeutics, Inc., Cynata Therapeutics, Human Longevity, Inc., Advanced Cell Technology, Inc., BIOTIME, Inc.Mesoblast Limited, Promethera Biosciences S.A. N.V., Merck Group, Takara Bio Group. Prominent market giants are emphasizing on product development and improvement which is increasing overall competition in the market.
In January 2019, The Cesca Therapeutics acquired ThermoGenesis Corp., and formed new wholly-owned ThermoGenesis subsidiary in order to focus on its Car-TXpress cellular processing platform. This acquisition was directed at commercializing and developing automated technologies as well as medical devices integrated in the therapies.
Market Segmentation
By Product
- Adult Stem Cells
- Neuronal Stem Cells
- Mesenchymal Stem Cells
- Dental Stem Cells
- Umbilical Cord Stem Cells
- Adipose-derived Stem Cells
- HematopoieticStem Cells
- Dedifferentiated fat (DFAT) Cells
- Other ASC’s
- Very Small Embryonic Like Stem Cells
- Human Embryonic Stem Cells
- Induced Pluripotent Stem Cells
By Application
- Regenerative Medicine
- Neurology
- Oncology
- Hematology
- Injuries
- Orthopedics
- Incontinence
- Diabetes
- Liver Disorder
- Others
- Drug Discovery and development
By Technology
- Cell Acquisition
- Apheresis
- Bone Marrow Harvest
- Umbilical Blood Cord
- Cryopreservation
- Cell production
- Therapeutic Cloning
- Cell Culture
- In-Vitro fertilization
- Isolation
- Expansion and Sub-Culture
By Therapy
- Allogenic Stem Cell Therapy
- Autologous Stem Cell Therapy
By Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Middle East & Africa
- Latin America
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Stem Cell Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Stem Cell Market
5.1. Covid-19: Stem Cell Industry Impact
5.2. Stem Cell Business Impact Assessment: Covid-19
5.2.1. Supply Chain Challenges/Disruption
5.2.2. Market Trends and Stem Cell Opportunities in the COVID-19 Landscape
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Stem Cell Manufacturers to deal with Covid-19 Pandemic Scenario
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Global Stem Cell Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Stem Cell Market Revenue by Manufacturer (2015-2020)
7.1.1.2. Stem Cell Market Revenue Market Share by Manufacturer (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Stem Cell Market, By Product Type
8.1. Stem Cell Market, by Product Type, 2016-2027
8.1.1. Adult Stem Cells
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Very Small Embryonic Like Stem Cells
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Human Embryonic Stem Cells
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Induced Pluripotent Stem Cells
8.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Stem Cell Market, By Application
9.1. Stem Cell Market, by Application, 2016-2027
9.1.1. Regenerative Medicine
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Drug Discovery and development
9.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Stem Cell Market, By Technology
10.1. Stem Cell Market, By Technology, 2016-2027
10.1.1. Cell Acquisition
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Cryopreservation
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Cell production
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Expansion and Sub-Culture
10.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 11. Global Stem Cell Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue Forecast by Product (2016-2027)
11.1.2. Market Revenue Forecast by Application (2016-2027)
11.1.3. Market Revenue Forecast By Technology (2016-2027)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2016-2027)
11.1.4.2. Market Revenue Forecast (2016-2027)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2016-2027)
11.1.5.2. Market Revenue Forecast (2016-2027)
11.2. Europe
11.2.1. Market Revenue Forecast by Product (2016-2027)
11.2.2. Market Revenue Forecast by Application (2016-2027)
11.2.3. Market Revenue Forecast By Technology (2016-2027)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2016-2027)
11.2.4.2. Market Revenue Forecast (2016-2027)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2016-2027)
11.2.5.2. Market Revenue Forecast (2016-2027)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2016-2027)
11.2.6.2. Market Revenue Forecast (2016-2027)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2016-2027)
11.2.7.2. Market Revenue Forecast (2016-2027)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product (2016-2027)
11.3.2. Market Revenue Forecast by Application (2016-2027)
11.3.3. Market Revenue Forecast By Technology (2016-2027)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2016-2027)
11.3.4.2. Market Revenue Forecast (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2016-2027)
11.3.5.2. Market Revenue Forecast (2016-2027)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2016-2027)
11.3.6.2. Market Revenue Forecast (2016-2027)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2016-2027)
11.3.7.2. Market Revenue Forecast (2016-2027)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product (2016-2027)
11.4.2. Market Revenue Forecast by Application (2016-2027)
11.4.3. Market Revenue Forecast by Technology (2016-2027)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2016-2027)
11.4.4.2. Market Revenue Forecast (2016-2027)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2016-2027)
11.4.5.2. Market Revenue Forecast (2016-2027)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product (2016-2027)
11.5.2. Market Revenue Forecast by Application (2016-2027)
11.5.3. Market Revenue Forecast by Technology (2016-2027)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2016-2027)
11.5.4.2. Market Revenue Forecast (2016-2027)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2016-2027)
11.5.5.2. Market Revenue Forecast (2016-2027)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2016-2027)
11.5.6.2. Market Revenue Forecast (2016-2027)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2016-2027)
11.5.7.2. Market Revenue Forecast (2016-2027)
Chapter 12. Company Profiles
12.1. Company 1
12.1.1. Company Overview, Business Information, Manufacturing Area
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue and Gross Margin (2015-2020)
12.1.4. Recent Developments and Strategies
12.2. STEMCELL Technologies, Inc.
12.2.1. Company Overview, Business Information, Manufacturing Area
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue and Gross Margin (2015-2020)
12.2.4. Recent Developments and Strategies
12.3. Osiris Therapeutics, Inc.
12.3.1. Company Overview, Business Information, Manufacturing Area
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue and Gross Margin (2015-2020)
12.3.4. Recent Developments and Strategies
12.4. Cynata Therapeutics
12.4.1. Company Overview, Business Information, Manufacturing Area
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue and Gross Margin (2015-2020)
12.4.4. Recent Developments and Strategies
12.5. Human Longevity, Inc.
12.5.1. Company Overview, Business Information, Manufacturing Area
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue and Gross Margin (2015-2020)
12.5.4. Recent Developments and Strategies
12.6. Advanced Cell Technology, Inc.
12.6.1. Company Overview, Business Information, Manufacturing Area
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue and Gross Margin (2015-2020)
12.6.4. Recent Developments and Strategies
12.7. BIOTIME, Inc.
12.7.1. Company Overview, Business Information, Manufacturing Area
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue and Gross Margin (2015-2020)
12.7.4. Recent Developments and Strategies
12.8. Mesoblast Limited
12.8.1. Company Overview, Business Information, Manufacturing Area
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue and Gross Margin (2015-2020)
12.8.4. Recent Developments and Strategies
12.9. Promethera Biosciences S.A. / N.V.
12.9.1. Company Overview, Business Information, Manufacturing Area
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue and Gross Margin (2015-2020)
12.9.4. Recent Developments and Strategies
12.10. Merck Group
12.10.1. Company Overview, Business Information, Manufacturing Area
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue and Gross Margin (2015-2020)
12.10.4. Recent Developments and Strategies
12.11. Takara Bio Group
12.11.1. Company Overview, Business Information, Manufacturing Area
12.11.2. Product Portfolio Analysis
12.11.2.1. Product Details, Specification, Application
12.11.3. Revenue and Gross Margin (2015-2020)
12.11.4. Recent Developments and Strategies
12.12. Company 12
12.12.1. Company Overview, Business Information, Manufacturing Area
12.12.2. Product Portfolio Analysis
12.12.2.1. Product Details, Specification, Application
12.12.3. Revenue and Gross Margin (2015-2020)
12.12.4. Recent Developments and Strategies
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1118
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 774 402 6168
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Blog: https://precedenceresearchnews.wordpress.com
Follow us on LinkedIn| Twitter| Facebook
0 Comments